Recently several groups have reported the existence of D-serine in serum (2), urine (3), and brain (4, 5) of mammals, including humans (6). Hashimoto et at (7) showed with biochemical techniques that the distribution of D-serine in rat brain regions parallels the distribution of N-methyl-D-aspartate (NMDA) subtypes of glutamate receptors. This is of interest because stimulation of NMDA receptors by glutamate requires the binding of glycine (8, 9) , and D-serine mimics glycine at these sites (10).
tor as visualized by autoradiography and are inversely correlated to the presence of D-amino acid oxidase. D-Serine is enriched in process-bearing glial cells in neuropil with the morphology of protoplasmic astrocytes. In glial cultures of rat cerebral cortex, D-serine is enriched in type 2 astrocytes. The release of D-serine from these cultures is stimulated by agonists of non-NMDA glutamate receptors, suggesting a mechanism by which astrocyte-derived D-serine could modulate neurotransmission. D-Serine appears to be the endogenous ligand for the glycine site of NMDA receptors. D amino acids have long been known to play a prominent role in bacterial physiology. There have been sporadic reports of endogenous D amino acids in animals, but mostly in invertebrates (1) . Recently several groups have reported the existence of D-serine in serum (2) , urine (3) , and brain (4, 5) of mammals, including humans (6) . Hashimoto et at (7) showed with biochemical techniques that the distribution of D-serine in rat brain regions parallels the distribution of N-methyl-D-aspartate (NMDA) subtypes of glutamate receptors. This is of interest because stimulation of NMDA receptors by glutamate requires the binding of glycine (8, 9) , and D-serine mimics glycine at these sites (10) .
To ascertain whether endogenous D-serine plays a physiologic role in neurotransmission, we have developed polyclonal antibodies that are selective for D-serine. We now report a localization of D-serine throughout rat brain that closely parallels NMDA receptors and is concentrated in gray-matter astrocytes of the telencephalon. We also demonstrate that D-serine is released from type 2 astrocyte cultures stimulated with agonists of non-NMDA glutamate receptors. (22 Ci/mmol; 1 Ci = 37 GBq) was provided by Steven Hurt (New England Nuclear). Antibody to glial fibrillary acidic protein (GFAP) was from Dako, and antibody to glutamine synthetase was from Chemicon. Glutaraldehyde was from EM sciences. Gold chloride was from Aldrich. Alkaline phosphatase-coupled anti-rabbit antibody was from The Jackson Laboratories. The peroxidase Elite staining kit was from Vector Laboratories. Glutamate receptor drugs were from Research Biochemicals (Natick, MA). Cell
MATERIALS AND METHODS

Materials. D-[3H]Serine
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Preparation of Polyclonal Antiserum to D-Serine. D-Serine was coupled to bovine serum albumin (BSA) with glutaraldehyde and then reduced with NaBH4 (11). After extensive dialysis against water, the conjugate was adsorbed to freshly prepared 45-nm colloidal gold particles (12) . A rabbit was immunized intradermally every 3 weeks with the BSA conjugate alone and intravenously with the gold particles. Before use, all D-serine antiserum used in this study was incubated for 2 hr at room temperature with Sepharose beads coupled to glutaraldehyde-treated BSA, to eliminate antibodies not selective for D-serine (13) . Liquid-phase conjugates of various amino acids to glutaraldehyde were prepared identically to the original immunogen, except that BSA was omitted and free aldehyde groups were blocked with excess Tris. For dot blot screens, various amino acids were coupled to dialyzed rat brain cytosol with glutaraldehyde as described above for D-serine/ BSA conjugates and then spotted on nitrocellulose. After overnight incubation with the primary antiserum, blots were visualized with an alkaline phosphatase-coupled anti-rabbit secondary antibody. High-affinity stereoselective antibodies appeared after 5 months of immunization.
Immunohistochemistry. Anesthetized rats (age, 45-50 days) were perfused through the aorta for 30 sec with 37°C oxygenated Krebs/Henseleit buffer and then at 60 ml/min with 500 ml of 37°C 5% glutaraldehyde/0.5% paraformaldehyde containing 0.2% Na2S2O5 in 0.1 M sodium phosphate (pH 7.4).
Brains were postfixed in the same buffer for 2 hr at room temperature. After cryoprotection for 2 days at 4°C in 50 mM sodium phosphate, pH 7.4/0.1 M NaCl/20% (vol/vol) glycerol, brain sections (20-40 ,um) were cut on a sliding microtome. Free-floating brain sections were reduced for 20 min with 0.5% NaBH4 and 0.2% Na2S2O5 in Tris-buffered saline (TBS: 50 mM Tris HCl, pH 7.4/0.15 M NaCl), washed for 45 min at room temperature in TBS containing 0.2% Na2S2O5, blocked with 4% normal goat serum for 1 hr in the presence of 0.2% Triton X-100, and incubated overnight at 4°C with the D-serine antiserum diluted 1:5000 to 1:1000 in TBS containing 2% goat serum and 0.1% Triton X-100. Immunoreactivity D-Amino Oxidase Enzyme Histochemistry. Anesthetized rats were perfused at 4°C with 500 ml of 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) and postfixed for 2 hr at 4°C. Free-floating tissue sections were incubated in the histochemistry medium described by Horiike et al (15) .
Primary Astrocyte Cultures. Mixed glial cultures were prepared from rat cerebral cortex at postnatal day 1-2 (16). After 10-12 days, the cultures were shaken for 1 hr at 37°C to deplete microglia and then shaken overnight to dislodge a population of type 2 astrocytes from the underlying layer of type 1 astrocytes. The dislodged cells were replated and grown for 2-5 days before use. For immunocytochemistry, cells were washed twice in phosphate-buffered saline and then fixed with 5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 hr at room temperature. In some experiments, cells were exposed to 50 AM kainate for 30 min before fixation.
D-[3H]
Serine Uptake and Release. Type 2 astrocyteenriched cultures were plated on poly(D-lysine)-coated 1.5-cm-diameter multiwell dishes and grown for 3-5 days. Release experiments were done as described by Levi and Patrizio (17) . In brief, each well was washed twice in 1 ml of oxygenated Krebs-Ringer medium and then incubated for 15 min at 37°C with 0.5 ,uCi of D-[3H]serine in 0.5 ml. Cells were then exposed continuously to glutamate-related drugs, and release of radioactivity into the medium was measured. Released radioactivity could be oxidzed by D-amino acid oxidase, confirming that it had not been metabolized by the cells.
RESULTS
To develop an antiserum to D-serine as it would occur in fixed brain tissue, we immunized rabbits with a glutaraldehyde conjugate of D-serine and BSA. To ascertain the sensitivity and specificity, we coupled various amino acids to dialyzed rat brain cytosol with glutaraldehyde and spotted the preparations onto nitrocellulose. Dot blots were probed with a 1:5000 dilution of the D-serine antibody in the presence or absence of 0.5 mM D-or L-serine glutaraldehyde conjugate (Fig. 1) . The antibody detects 0.01 nmol of D-serine but not 0.001 nmol. The antibody is about 100-fold less sensitive to L-serine than to D-serine and shows even less IR to glycine, L-glutamate, L-alanine, and D-aspartate, with no reactivity to y-aminobutyrate. Preabsorption of the antibody with 0.5 mM L-serine glutaraldehyde conjugate (Fig. 1 Center) abolishes the small amounts of crossreactivitywith other amino acids but diminishes sensitivity to D-serine minimally; preabsorption with the same concentration of D-serine glutaraldehyde conjugate eliminates IR (Fig. 1 Left) . Likewise, in tissue sections, the D-serine conjugate eliminates IR (data not shown).
Immunohistochemical staining of rat brain reveals highly selective localizations of D-serine (Fig. 2 Top) . IR is concentrated in the telencephalon, with very low levels in the hindbrain. The most intense IR occurs in the anterior olfactory nuclei, olfactory tubercle, hippocampus, rostral cerebral cortex (especially superficial layers), and corpus striatum. Intense IR also occurs in the amygdala (data not shown). IR occurs throughout all neuropil in the hippocampus and in the hilus of the dentate gyrus, but is much less in the pyramidal cell layer and is absent from the granule cell layer of the dentate gyrus. Substantial IR occurs in the thalamus and hypothalamus. The midbrain, pons, and medulla have almost negligible IR. In the cerebellar molecular layer, IR is lower than in the forebrain but is clearly present relative to other parts of the cerebellum, which are unstained.
The Horiike et at (15, 18, 19) have observed that D-amino acid oxidase is concentrated in astrocytes of the hindbrain and cerebellum. We confirm these findings. The localization of D-amino acid oxidase is almost exactly the inverse of D-serine, and no D-amino acid oxidase is detected in the telencephalon. The molecular layer of the cerebellum is a special case; not only does it possess the highest levels of D-amino acid oxidase activity in brain, but it is also the only region where D-serine and D-amino acid oxidase appear colocalized.
The presence of endogenous D-serine in telencephalic gray matter enriched in NMDA receptors suggested that D-serine might exist in neurons. We were surprised to observe under high magnification that D-serine IR was associated exclusively with glia. We observe no D-serine-immunopositive neurons in any brain region (Fig. 3) . D-Serine-positive glia have small cell bodies and are bipolar or multipolar. IR is concentrated in cell bodies and proximal processes and appears punctate and intracellular. In neuropil, IR is present not only in individual cells but also appears to fill most of the extraneuronal space. In the lower blade of the dentate gyrus and in layer 1 of the cerebral cortex, D-serine-positive cells orient their processes toward the pial surface. In the frontal cortex, immunostained cells are often oriented radially along pyramidal cell processes, while in the deep cortex and striatum, D-serine cells have no obvious pattern. In fiber tracts of the telencephalon, numerous intensely labeled cells stand out against an unstained background. Immunoreactive cells are numerous around blood vessels, suggesting that they are astrocytes. In double-labeling experiments (data not shown), we observe D-serine-immunopositive cells which are also positive for the astrocytic markers GFAP or glutamine synthetase. However, a substantial portion of D-serine-immunopositive glial cells are GFAP negative.
To determine which glial types make D-serine, we prepared glial cultures from cerebral cortex (16) . In primary mixed glial cultures, type 1 astrocytes are polygonal and form a confluent layer on the culture dish; process-bearing type 2 astrocytes, oligodendrocytes, 02A progenitors, and microglia grow on top. Many cells in this top layer display strong D-serine IR, while the underlying type 1 cells display a weaker but still detectable IR. Enriched fractions of type 2 astrocytes are obtained by overnight shaking of the culture flask. Almost all of these cells stain positively for D-serine (Fig. 4) . About half of these cells are positive for the astrocytic marker GFAP, and most are positive for glutamine synthetase (data not shown). (Fig. 4) . In comparison with identical cultures of unstimulated cells, we observe a substantial reduction of IR in the kainate-treated cultures. The difference between stimulated and unstimulated cultures is apparent upon gross examination of the immunolabeled slides, even without microscopy.
DISCUSSION
The main findings of this study are that D-serine is localized to multipolar glia in areas of the brain enriched in NMDA receptors and that D-serine release from type 2 astrocytes is selectively enhanced by non-NMDA glutamate receptor agonists. Glycine is often called a "coagonist" with glutamate at the NMDA receptor, since occupation of the glycine site is absolutely required to gate the channel (10, 21 NMDA receptors in vivo, indicating that the sites are not normally saturated (22) (23) (24) .
We suggest that the predominant endogenous ligand for the glycine site is D-serine and not glycine. D-Serine levels in cerebral cortex (5, 7) are about a third of glycine levels (7, 25) . D-Serine is concentrated in gray-matter astrocytes near NMDA receptors.
In contrast, the regional distribution of glycine in the telencephalon does not match NMDA receptors. Immunohistochemical studies using antibodies specific for glycine (11, 26, 27) (28) (29) (30) . In terms of its overall localization throughout the brain, the distribution of glycine is virtually the opposite of NMDA receptors (25) .
In (34) (35) (36) (37) . Our results show that type 2 astrocytes release D-serine when stimulated with non-NMDA glutamate receptor agonists. These data are consistent with D-serine release occurring through a carrier-mediated mechanism (20) . In this model the depolarization of nerve terminals releases glutamate, which in turn stimulates ionotropic glutamate receptors on type 2 astrocytes. The influx of Na+ may allow Na+-dependent amino acid transporters to function in reverse (Fig. 6) .
At any synapse where the glycine site is not fully occupied, activation of NMDA receptors may be a coordinated process whereby glutamate released by the presynaptic neuron relieves the Mg2+ block and binds to the NMDA site, and then D-serine released from astrocytes binds to the glycine site to gate the channel. Since D-serine uptake in brain occurs poorly relative to L-serine or glycine uptake (M.J.S. and S.H.S., unpublished data), and no known enzymes can metabolize D-serine in the telencephalon, D-serine may remain in the synaptic space longer than conventional neurotransmitters.
By analogy with bacterial enzymes, most mechanisms proposed for the biosynthesis of D-serine in worms and insects involve a racemase (1) . A particularly tempting possibility for D-serine biosynthesis in brain involves the glycine cleavage pathway (38), a multienzyme complex localized to the mitochondria and capable of transforming glycine to serine. The regional distribution of glycine cleavage activity in the brain + CNQX, 30 resembles that of D-serine (38) , and immunohistochemical mapping of the P-protein component of the glycine cleavage complex in brain reveals localizations to the mitochondria of process-bearing astrocytes in the telencephalon (39) . Further study may reveal whether the glycine cleavage pathway is strictly chiral.
